Journal of Hematology and Oncology

Top Research Topics at Journal of Hematology & Oncology?

Journal of Hematology & Oncology facilitates discussions on Internal medicine, Cancer research, Hematology, Oncology and Immunology. The featured Internal medicine studies mainly concentrate on Gastroenterology but also cover areas of interest in Surgery. While work presented in the journal provided substantial information on Cancer research, it also covered topics in T cell, Metastasis, Cell growth and Immunotherapy.

The study of Immune system serves as the foundation of the Immunotherapy research discussed in Journal of Hematology & Oncology. It facilitates discussions on Hematology that incorporate concepts from other fields like Clinical trial, Chemotherapy, Lymphoma, Bone marrow and Multiple myeloma. Haematopoiesis and Stem cell are some topics wherein Bone marrow research discussed in Journal of Hematology & Oncology have an impact.

Lung cancer is part of Oncology studies tackled in Journal of Hematology & Oncology. The journal links adjacent topics like Immunology with Hematopoietic stem cell transplantation. Cancer cell and Carcinogenesis studies are all carried out as a component of the study in Cancer presented.

• Internal medicine (53.29%)
• Cancer research (44.86%)
• Hematology (40.38%)

What are the most cited papers published in the journal?

• The effects of β-glucan on human immune and cancer cells (519 citations)
• Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers (431 citations)
• Exosomes in cancer: small particle, big player (414 citations)

Research areas of the most cited articles at Journal of Hematology & Oncology:

The journal papers investigate studies in Cancer research, Internal medicine, Hematology, Cancer and Immunology. The published articles with studies in Cancer research featured incorporate elements of Tyrosine kinase, microRNA, Metastasis and Cancer immunotherapy. The journal papers feature Internal medicine research that overlaps with concepts in Oncology.

What topics the last edition of the journal is best known for?

• Cancer
• Gene
• Internal medicine

The previous edition focused in particular on these issues:

Journal of Hematology & Oncology investigates studies in Internal medicine, Hematology, Cancer research, Oncology and Cancer. It focuses on Internal medicine but sometimes tackles the closely related topic of Gastroenterology which is concerned with Clinical endpoint and Prospective cohort study. Concepts in Chimeric antigen receptor, as well as related topics in Cell therapy and B cell, are covered in the Hematology research presented in the journal.

Journal of Hematology & Oncology explores topics in Cancer research which can be helpful for research in disciplines like T cell, Cell, Metastasis and Immunotherapy. Issues in Oncology were discussed, taking into consideration concepts from other disciplines like Minimal residual disease, Disease, Cytokine release syndrome and Lymphoma. It focuses on Cancer but the discussions also offer insight into other areas such as Exosome, Bioinformatics and Cell biology.

The most cited articles from the last journal are:

• NK cell-based cancer immunotherapy: from basic biology to clinical development (24 citations)
• Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. (23 citations)
• Regulation of PD-L1 expression in the tumor microenvironment. (22 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Journal of Hematology & Oncology (based on the number of publications) are:

• Delong Liu (53 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• Mohamad Mohty (27 papers) published 3 papers at the last edition, 1 less than at the previous edition,
• Yangqiu Li (25 papers) absent at the last edition,
• Myriam Labopin (25 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• Arnon Nagler (24 papers) published 3 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Hematology & Oncology (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (86 papers) published 10 papers at the last edition, 3 more than at the previous edition,
• Zhengzhou University (83 papers) published 12 papers at the last edition, 3 less than at the previous edition,
• Peking Union Medical College (81 papers) published 18 papers at the last edition, 5 more than at the previous edition,
• Peking University (70 papers) published 8 papers at the last edition the same number as at the previous edition,
• Zhejiang University (65 papers) published 17 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.17% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 39.13% were posted by at least one author from the top 10 institutions publishing in the journal. Another 19.25% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.04% of all publications and 28.57% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Outlook for Hematology & Oncology Researchers

The field of Hematology and Oncology is vast and opportunities abound for professionals, especially researchers with specific focus in this discipline. The analysis of the Journal of Hematology & Oncology provides a wealth of knowledge not only in terms of academic insights into the field but also from a career perspective. Career prospects for Hematology & Oncology researchers might include working as a nurse practitioner, provided the necessary training and additional certification is achieved. Nurse practitioners are in high demand in the healthcare industry, especially those with a specialty in Hematology & Oncology. Georgia, for instance, offers several top-notch degree programs for aspiring nurse practitioners. More of this can be found in our previous reviews of the best nurse practitioner programs in Georgia. In addition to clinical roles, many graduates of these programs go on to work in research, university teaching, pharmaceutical industries, or hospital administration. It is also not uncommon to see these professionals publishing their research findings regularly in renowned journals like the Journal of Hematology & Oncology, thereby contributing significantly to advancements in the field. By analyzing the current research trends and the most cited articles, we can understand the areas of this discipline that are currently at the forefront of discovery. Finally, it's important to note that while the demand for Hematology & Oncology expertise is expected to grow, the journey towards a successful career in this field requires commitment to continuous learning and staying updated with latest developments through scientific publications like the Journal of Hematology & Oncology.